Prostate cancer in Korean men exhibits poor differentiation and is adversely related to prognosis after radical prostatectomy

Urology

Volumn 68, Issue 4, 2006, Pages 820-824

  Song, Cheryn ^a   Ro, Jae Y ^a   Lee, Moo Song ^a   Hong, Sung Joon ^b   Chung, Byung Ha ^b   Choi, Han Yong ^c   Lee, Sang Eun ^d   Lee, Eunsik ^d   Kim, Choung Soo ^a   Ahn, Hanjong ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Sungkyunkwan University School of Medicine   (South Korea)

^d Seoul National University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANALYTICAL PARAMETERS; ANTIGEN DETECTION; ARTICLE; BLOOD LEVEL; CANCER STAGING; CANCER SURGERY; CHEMICAL ANALYSIS; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; ETHNIC DIFFERENCE; FOLLOW UP; GLEASON SCORE; HUMAN; HUMAN TISSUE; KOREA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; STATISTICAL SIGNIFICANCE; TUMOR BIOPSY;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 33750320410     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2006.04.029     Document Type: Article

References (21)

1. Whittemore A.S. Prostate cancer. In: Doll R., Fraumeni Jr. J.F., and Muir C.S. (Eds). Cancer Surveys: Trends in Cancer Incidence and Mortality vol 19 (1994), Cold Spring Harbor Laboratory Press, New York 309-322
2. Cancer Registration and Biostatistics Branch, National Cancer Center. Cancer Statistics in Korea (2003)
3. Song C., Kang T., Ro J.Y., et al. Nomograms for the prediction of pathologic stage of clinically localized prostate cancer in Korean men. J Korean Med Sci 20 (2005) 262-266
4. Roehl K.A., Han M., Ramos C.G., et al. Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results. J Urol 172 (2004) 910-914
5. D'Amico A.V., Whittington R., Malkowicz S.B., et al. Clinical utility of the percentage of positive prostate biopsies in defining biochemical outcome after radical prostatectomy for patients with clinically localized prostate cancer. J Clin Oncol 18 (2000) 1164-1172
6. Pound C.R., Partin A.W., Eisenberger M.A., et al. Natural history of progression after PSA elevation following radical prostatectomy. JAMA 281 (1999) 1591-1597
7. Hull G.W., Rabbani F., Abbas F., et al. Cancer control with radical prostatectomy alone in 1,000 consecutive patients. J Urol 167 (2002) 528-534
8. Latini D.M., Elkin E.P., Cooperberg M.R., et al. Differences in clinical characteristics and disease-free survival for Latino, African-American, and non-Latino white men with prostate cancer: data from CaPSURE. J Urol 171 suppl 4 (2004) 124
9. Lam J.S., Sclar J.D., Desai M., et al. Is Hispanic race an important predictor of treatment failure following radical prostatectomy for prostate cancer?. J Urol 172 (2004) 1856-1859
10. Egawa S., Suyama K., Arai Y., et al. A study of pretreatment nomograms to predict pathological stage and biochemical recurrence after radical prostatectomy for clinically respectable prostate cancer in Japanese men. Jpn J Clin Oncol 31 (2001) 74-181
11. Hsu Y.S., Wang J.S., and Wu T.T. E-cadherin expression in prostate adenocarcinoma in Chinese and its pathological correlates. Urol Int 73 (2004) 36-40
12. Egawa S., Suyama K., Arai Y., et al. Treatment outcome by risk group after radical prostatectomy in Japanese men. Int J Urol 8 (2001) 295-300
13. Freedland S.J., Mangold L.A., Walsh P.C., et al. The prostatic specific antigen era is alive and well: prostatic specific antigen and biochemical progression following radical prostatectomy. J Urol 174 (2005) 1276-1281
14. Man A., Pickles T., Chi K.N., et al. Asian race and impact on outcomes after radical radiotherapy for localized prostate cancer. J Urol 170 (2003) 901-904
15. Derweesh I.H., Kupelian P.A., Zippe C., et al. Continuing trends in pathological stage migration in radial prostatectomy specimens. Urol Oncol 22 (2004) 300-306
16. van Houten M.E., and Gorren L.J.G. Differences in reproductive endocrinology between Asian men and Caucasian men-a literature review. Asian J Androl 2 (2000) 13-20
17. Wu A.H., Whittemore A.S., Kolonel L.N., et al. Lifestyle determinants of 5α-reductase metabolites in older African-American, white, and Asian-American men. Cancer Epidemiol Biomarkers Prev 10 (2001) 533-538
18. Hoffman M.A., DeWolf W.C., and Morgentaler A. Is low serum free testosterone a marker for high grade prostate cancer?. J Urol 163 (2000) 824-827
19. Zhang P.L., Rosen S., Veeramachaneni R., et al. Association between prostate cancer and serum testosterone levels. Prostate 53 (2002) 179-182
20. Massengill J.C., Sun L., Moul J.W., et al. Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomy. J Urol 169 (2003) 1670-1675
21. Raivio T., Santti H., Schatzl G., et al. Reduced circulating androgen bioactivity in patients with prostate cancer. Prostate 55 (2003) 194-198